HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoko Takezaki Selected Research

Tumor Necrosis Factor Inhibitors

1/2017Tumor Necrosis Factor Inhibitors Provide Longterm Clinical Benefits in Pediatric and Young Adult Patients with Blau Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoko Takezaki Research Topics

Disease

3Juvenile Arthritis (Juvenile Idiopathic Arthritis)
03/2019 - 01/2008
2Blau syndrome
03/2019 - 01/2017
1Pneumococcal Infections
01/2020
1Bacteremia
01/2020
1Familial Mediterranean Fever (Periodic Disease)
03/2019
1Infections
01/2016
1Arthritis (Polyarthritis)
01/2008

Drug/Important Bio-Agent (IBA)

2VaccinesIBA
01/2020 - 01/2016
2S100A12 ProteinIBA
03/2019 - 07/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2019 - 07/2016
2Methotrexate (Mexate)FDA LinkGeneric
07/2016 - 01/2008
1Tumor Necrosis Factor InhibitorsIBA
01/2017
1Rheumatoid FactorIBA
01/2008
1Infliximab (Remicade)FDA Link
01/2008